Monroe Bank & Trust’s GSK GSK Stock Holding History

Monroe Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-480	Closed	-$24K	–	156
2018 Q2	$24K	Hold	480	–	–	0.01%	177
2018 Q1	$23K	Sell	480 -520	-52%	-$24.2K	0.01%	187
2017 Q4	$44K	Buy	+1,000	New	+$46.2K	0.01%	161
2017 Q3	–	Sell	-480	Closed	-$26K	–	167
2017 Q2	$26K	Hold	480	–	–	0.01%	188
2017 Q1	$25K	Sell	480 -720	-60%	-$36.5K	0.01%	193
2016 Q4	$58K	Buy	+1,200	New	+$59.3K	0.02%	162
2016 Q2	–	Sell	-1,200	Closed	-$61K	–	198
2016 Q1	$61K	Hold	1,200	–	–	0.02%	166
2015 Q4	$61K	Hold	1,200	–	–	0.02%	167
2015 Q3	$58K	Hold	1,200	–	–	0.02%	167
2015 Q2	$62K	Hold	1,200	–	–	0.02%	162
2015 Q1	$69K	Hold	1,200	–	–	0.02%	161
2014 Q4	$64K	Buy	+1,200	New	+$67.1K	0.02%	166
2014 Q3	–	Sell	-1,200	Closed	-$80K	–	192
2014 Q2	$80K	Hold	1,200	–	–	0.03%	177
2014 Q1	$80K	Buy	1,200 +480	+67%	+$32.5K	0.03%	184
2013 Q4	$48K	Hold	720	–	–	0.02%	178
2013 Q3	$45K	Hold	720	–	–	0.02%	181
2013 Q2	$45K	Buy	+720	New	+$45.7K	0.02%	179

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Monroe Bank & Trust's GSK Position: Q3 2018 in Review

Monroe Bank & Trust sold out of GSK (GSK) in Q3 2018, closing a stake of 480 shares — an estimated $24K sold.

Monroe Bank & Trust first reported a position in GSK in Q2 2013 and held it in 17 quarters. The position peaked at $80K in Q2 2014. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

Monroe Bank & Trust reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
Monroe Bank & Trust sold 480 GSK shares in Q3 2018, an estimated $24K.
Monroe Bank & Trust first reported a position in GSK in Q2 2013 and held it in 17 quarters.
Monroe Bank & Trust's GSK position peaked at $80K in Q2 2014.
787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Monroe Bank & Trust's 13F filing for Q3 2018, filed 14 Nov 2018.